Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
News Focus
Investors: Take Advantage of Double Fed Tax Credits on Critical Minerals Project (click to learn more)
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Breaking & Recent News VentriPoint Diagnostics Ltd V.VPT

Alternate Symbol(s):  VPTDF

Healthcare Medical Devices
Ventripoint Diagnostics Ltd is a Canada-based medical device company. The Company is engaged in the development and commercialization of diagnostic tools that monitor patients with heart disease. It is developing a suite of applications for all heart diseases and imaging modalities, including congenital heart disease, pregnancy, pulmonary hypertension, COVID-19, imaging, and cardiotoxicity in... see more

Recent & Breaking News (TSXV:VPT)

Ventripoint Diagnostics Reports Third Quarter 2023 Financial Results

TheNewsWire 3 days ago

Ventripoint Announces Date and Timing for Release of Q3 2023 Financial Results and Webinar

TheNewsWire 9 days ago

Ventripoint to Demonstrate AI-powered Heart Imaging Technology at The British Congenital Cardiac Association Annual Conference

TheNewsWire November 9, 2023

Ventripoint Diagnostics Reports Results of Annual General & Special Shareholders Meeting

TheNewsWire November 3, 2023

Ventripoint to Hold Annual General Meeting of Shareholders on November 1, 2023

TheNewsWire October 24, 2023

Ventripoint AI Heart Imaging Technology To Be Presented at British Society of Echocardiography Annual Conference

TheNewsWire October 12, 2023

Ventripoint Announces Appointment of Chief Finance Officer

TheNewsWire October 3, 2023

Ventripoint's AI Heart Technology Takes Centre Stage In ITN Business "The Hidden Heart" Programme

TheNewsWire September 28, 2023

Ventripoint to Sponsor DGPK Echo Advanced Workshop

TheNewsWire September 15, 2023

Ventripoint to Sponsor 51st Annual Nordic Paediatric Cardiology Meeting

TheNewsWire September 13, 2023

Ventripoint Announced as Gold Sponsor for the 8th Annual Paediatric Echo Society Symposium

TheNewsWire September 8, 2023

Ventripoint Diagnostics Reports Second Quarter 2023 Financial Results

TheNewsWire August 30, 2023

Ventripoint Announces Date and Timing for Release of Q2 2023 Financial Results and Webinar

TheNewsWire August 25, 2023

Healthcare AI stock unveils innovative cardiovascular product

Trevor Abes  August 18, 2023

Ventripoint Unveils New Integrated Product with ASCEND Cardiovascular

TheNewsWire August 18, 2023

Ventripoint Announces Collaboration with Ascend Cardiovascular

TheNewsWire August 10, 2023

Ventripoint Diagnostics to Attend 8th World Congress of Paediatric Cardiology and Cardiac Surgery

TheNewsWire August 2, 2023

Ventripoint's VMS+ Purchased by Medical Center - University of Freiburg

TheNewsWire July 18, 2023

Ventripoint to Sponsor Advanced Imaging 2023 in London, England

TheNewsWire July 11, 2023

Ventripoint Diagnostics Makes Significant Sale to the Largest Heart Center in Germany

TheNewsWire July 5, 2023